In CRC cells, SIRT3 downregulates K88 acetylation of MTHFD2 to maintain MTHFD2 enzyme activity and NADPH production, and cisplatin disrupts these processes by inhibiting SIRT3 expression [127]. This evidence concerns the gene SIRT3 and colorectal carcinoma.